Post by Harvard Innovation Labs

Early detection can make a life-changing difference in cancer care, but access to timely screening and specialist expertise remains deeply uneven. That challenge is what led Founder Mario Minor Murakami Junior (Harvard Medical School '26), a postdoc at Harvard Medical School, to create AI Pathology; a venture using artificial intelligence to help support earlier cancer detection and strengthen care delivery in underserved communities. Drawing on experience in medicine, computer science, and imaging research, the AI Pathology team is building tools designed to help clinicians and frontline health workers identify concerning skin lesions sooner and make more informed decisions. In a recent conversation with the Harvard Innovation Labs, Murakami shares what inspired him to start AI Pathology, the responsibility that comes with building in health care, and the unexpected moments that shaped the company’s journey. Read more: https://lnkd.in/e-4G2RKx